Citigroup’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4
Closed -$20 4996
2024
Q1
$20 Sell
4
-94
-96% -$470 ﹤0.01% 4747
2023
Q4
$661 Sell
98
-27
-22% -$182 ﹤0.01% 4680
2023
Q3
$1.14K Sell
125
-2
-2% -$18 ﹤0.01% 4319
2023
Q2
$2.69K Buy
127
+12
+10% +$254 ﹤0.01% 4515
2023
Q1
$3.08K Sell
115
-275
-71% -$7.37K ﹤0.01% 4326
2022
Q4
$13.8K Buy
390
+250
+179% +$8.85K ﹤0.01% 4025
2022
Q3
$32K Sell
140
-123
-47% -$28.1K ﹤0.01% 3860
2022
Q2
$50K Buy
263
+60
+30% +$11.4K ﹤0.01% 3863
2022
Q1
$50K Sell
203
-279
-58% -$68.7K ﹤0.01% 4033
2021
Q4
$75K Buy
482
+151
+46% +$23.5K ﹤0.01% 4119
2021
Q3
$66K Buy
331
+70
+27% +$14K ﹤0.01% 3855
2021
Q2
$66K Sell
261
-12
-4% -$3.03K ﹤0.01% 4017
2021
Q1
$72K Sell
273
-1,871
-87% -$493K ﹤0.01% 3865
2020
Q4
$791K Buy
2,144
+143
+7% +$52.8K ﹤0.01% 2334
2020
Q3
$489K Sell
2,001
-18
-0.9% -$4.4K ﹤0.01% 2261
2020
Q2
$581K Sell
2,019
-99
-5% -$28.5K ﹤0.01% 2458
2020
Q1
$432K Buy
2,118
+1,894
+846% +$386K ﹤0.01% 2366
2019
Q4
$100K Buy
224
+159
+245% +$71K ﹤0.01% 3547
2019
Q3
$19K Sell
65
-177
-73% -$51.7K ﹤0.01% 4311
2019
Q2
$76K Sell
242
-697
-74% -$219K ﹤0.01% 3810
2019
Q1
$394K Buy
939
+935
+23,375% +$392K ﹤0.01% 2668
2018
Q4
$1K Hold
4
﹤0.01% 4967
2018
Q3
$2K Hold
4
﹤0.01% 4934
2018
Q2
$2K Hold
4
﹤0.01% 4867
2018
Q1
$1K Hold
4
﹤0.01% 4862
2017
Q4
$2K Hold
4
﹤0.01% 4828
2017
Q3
$1K Hold
4
﹤0.01% 4632
2017
Q2
$1K Sell
4
-6
-60% -$1.5K ﹤0.01% 4772
2017
Q1
$4K Buy
10
+5
+100% +$2K ﹤0.01% 4533
2016
Q4
$2K Buy
5
+1
+25% +$400 ﹤0.01% 4767
2016
Q3
$2K Sell
4
-14
-78% -$7K ﹤0.01% 4790
2016
Q2
$11K Buy
18
+12
+200% +$7.33K ﹤0.01% 4482
2016
Q1
$3K Buy
6
+2
+50% +$1K ﹤0.01% 5070
2015
Q4
$3K Sell
4
-8
-67% -$6K ﹤0.01% 5103
2015
Q3
$6K Sell
12
-6
-33% -$3K ﹤0.01% 4585
2015
Q2
$10K Buy
18
+7
+64% +$3.89K ﹤0.01% 4603
2015
Q1
$96K Hold
11
﹤0.01% 3430
2014
Q4
$97K Buy
+11
New +$97K ﹤0.01% 3671
2014
Q2
Hold
0
-$2K 5669
2014
Q1
Hold
0
5249